Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

GE Healthcare CEO aims to grow from within

John Flannery built a reputation as a prolific rainmaker in his previous role as head of business development at General Electric Co., logging more than $26 billion in deals, yet acquisitions are far from his mind as chief executive of the U.S. conglomerate’s healthcare unit.

Wellmark raising exchange premiums up to 43 percent in Iowa

The insurer covers more than 30,000 Iowans through the exchange, representing about about 75 percent of all individual policies in Iowa's market. 

Thumbnail

Study: Healthcare costs drop quickly after smokers quit

A study conducted by the University of California, San Francisco, estimates that a 10 percent decline in smoking in the U.S. would be followed by a $63 billion reduction in total healthcare costs for the following year.

St. David’s HealthCare to buy Forest Park hospital in Texas

St. David’s HealthCare announced plans to buy Forest Park Medical Center’s Austin hospital for $115 million, reports BizJournal.

Aetna to remain in all current exchanges in 2017, teases expansion

Aetna’s filings with regulators “preserved our options to enter certain new geographies pending careful evaluation of marketplace conditions.” 

Will healthcare get a 'Silicon Valley-style overhaul'?

The healthcare industry is falling behind in the terms of technology. While almost every other industry is embracing the technological age, healthcare seems to be stuck in the 1990’s.

New tool can estimate cost of inaction

The healthcare analytics company has announced the launch of a free tool used to calculate the real cost of delaying the shift from public and private payer volume to value-based care and reimbursement.

Survey: Majority can't afford long-term care

With the average American living well past the age of 65, the chance of needing long-term care is about 52 percent for most people. Sadly, the cost of care is something that most people cannot afford.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.